Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study

Abstract Cognitive behavioral therapy (CBT) is often recommended as a first-line treatment in depression. However, access to CBT remains limited, and up to 50% of patients do not benefit from this therapy. Identifying biomarkers that can predict which patients will respond to CBT may assist in desig...

Full description

Bibliographic Details
Main Authors: Benjamin Schwartzmann, Lena C. Quilty, Prabhjot Dhami, Rudolf Uher, Timothy A. Allen, Stefan Kloiber, Raymond W. Lam, Benicio N. Frey, Roumen Milev, Daniel J. Müller, Claudio N. Soares, Jane A. Foster, Susan Rotzinger, Sidney H. Kennedy, Faranak Farzan
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-35179-4
_version_ 1827939894790455296
author Benjamin Schwartzmann
Lena C. Quilty
Prabhjot Dhami
Rudolf Uher
Timothy A. Allen
Stefan Kloiber
Raymond W. Lam
Benicio N. Frey
Roumen Milev
Daniel J. Müller
Claudio N. Soares
Jane A. Foster
Susan Rotzinger
Sidney H. Kennedy
Faranak Farzan
author_facet Benjamin Schwartzmann
Lena C. Quilty
Prabhjot Dhami
Rudolf Uher
Timothy A. Allen
Stefan Kloiber
Raymond W. Lam
Benicio N. Frey
Roumen Milev
Daniel J. Müller
Claudio N. Soares
Jane A. Foster
Susan Rotzinger
Sidney H. Kennedy
Faranak Farzan
author_sort Benjamin Schwartzmann
collection DOAJ
description Abstract Cognitive behavioral therapy (CBT) is often recommended as a first-line treatment in depression. However, access to CBT remains limited, and up to 50% of patients do not benefit from this therapy. Identifying biomarkers that can predict which patients will respond to CBT may assist in designing optimal treatment allocation strategies. In a Canadian Biomarker Integration Network for Depression (CAN-BIND) study, forty-one adults with depression were recruited to undergo a 16-week course of CBT with thirty having resting-state electroencephalography (EEG) recorded at baseline and week 2 of therapy. Successful clinical response to CBT was defined as a 50% or greater reduction in Montgomery-Åsberg Depression Rating Scale (MADRS) score from baseline to post-treatment completion. EEG relative power spectral measures were analyzed at baseline, week 2, and as early changes from baseline to week 2. At baseline, lower relative delta (0.5–4 Hz) power was observed in responders. This difference was predictive of successful clinical response to CBT. Furthermore, responders exhibited an early increase in relative delta power and a decrease in relative alpha (8–12 Hz) power compared to non-responders. These changes were also found to be good predictors of response to the therapy. These findings showed the potential utility of resting-state EEG in predicting CBT outcomes. They also further reinforce the promise of an EEG-based clinical decision-making tool to support treatment decisions for each patient.
first_indexed 2024-03-13T09:01:26Z
format Article
id doaj.art-40d35cf6aa3e4b00bfc2b664c56cefa4
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-13T09:01:26Z
publishDate 2023-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-40d35cf6aa3e4b00bfc2b664c56cefa42023-05-28T11:16:37ZengNature PortfolioScientific Reports2045-23222023-05-0113111210.1038/s41598-023-35179-4Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression studyBenjamin Schwartzmann0Lena C. Quilty1Prabhjot Dhami2Rudolf Uher3Timothy A. Allen4Stefan Kloiber5Raymond W. Lam6Benicio N. Frey7Roumen Milev8Daniel J. Müller9Claudio N. Soares10Jane A. Foster11Susan Rotzinger12Sidney H. Kennedy13Faranak Farzan14eBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser UniversityUniversity of TorontoeBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser UniversityDepartment of Psychiatry, Dalhousie UniversityCentre for Addiction and Mental HealthUniversity of TorontoDepartment of Psychiatry, University of British ColumbiaDepartment of Psychiatry and Behavioural Neurosciences, McMaster UniversityDepartment of Psychiatry, Providence Care, Queen’s UniversityUniversity of TorontoDepartment of Psychiatry, Providence Care, Queen’s UniversityDepartment of Psychiatry and Behavioural Neurosciences, McMaster UniversityUniversity of TorontoUniversity of TorontoeBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser UniversityAbstract Cognitive behavioral therapy (CBT) is often recommended as a first-line treatment in depression. However, access to CBT remains limited, and up to 50% of patients do not benefit from this therapy. Identifying biomarkers that can predict which patients will respond to CBT may assist in designing optimal treatment allocation strategies. In a Canadian Biomarker Integration Network for Depression (CAN-BIND) study, forty-one adults with depression were recruited to undergo a 16-week course of CBT with thirty having resting-state electroencephalography (EEG) recorded at baseline and week 2 of therapy. Successful clinical response to CBT was defined as a 50% or greater reduction in Montgomery-Åsberg Depression Rating Scale (MADRS) score from baseline to post-treatment completion. EEG relative power spectral measures were analyzed at baseline, week 2, and as early changes from baseline to week 2. At baseline, lower relative delta (0.5–4 Hz) power was observed in responders. This difference was predictive of successful clinical response to CBT. Furthermore, responders exhibited an early increase in relative delta power and a decrease in relative alpha (8–12 Hz) power compared to non-responders. These changes were also found to be good predictors of response to the therapy. These findings showed the potential utility of resting-state EEG in predicting CBT outcomes. They also further reinforce the promise of an EEG-based clinical decision-making tool to support treatment decisions for each patient.https://doi.org/10.1038/s41598-023-35179-4
spellingShingle Benjamin Schwartzmann
Lena C. Quilty
Prabhjot Dhami
Rudolf Uher
Timothy A. Allen
Stefan Kloiber
Raymond W. Lam
Benicio N. Frey
Roumen Milev
Daniel J. Müller
Claudio N. Soares
Jane A. Foster
Susan Rotzinger
Sidney H. Kennedy
Faranak Farzan
Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
Scientific Reports
title Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
title_full Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
title_fullStr Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
title_full_unstemmed Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
title_short Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
title_sort resting state eeg delta and alpha power predict response to cognitive behavioral therapy in depression a canadian biomarker integration network for depression study
url https://doi.org/10.1038/s41598-023-35179-4
work_keys_str_mv AT benjaminschwartzmann restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT lenacquilty restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT prabhjotdhami restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT rudolfuher restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT timothyaallen restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT stefankloiber restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT raymondwlam restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT benicionfrey restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT roumenmilev restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT danieljmuller restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT claudionsoares restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT janeafoster restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT susanrotzinger restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT sidneyhkennedy restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy
AT faranakfarzan restingstateeegdeltaandalphapowerpredictresponsetocognitivebehavioraltherapyindepressionacanadianbiomarkerintegrationnetworkfordepressionstudy